This website uses cookies to store information on your computer. Some of these cookies are used for visitor analysis, others are essential to making our site function properly and improve the user experience. By using this site, you consent to the placement of these cookies. Click Accept to consent and dismiss this message or Deny to leave this website. Read our Privacy Statement for more.
Join BNMS | Print Page | Contact Us | Sign In
News & Press: Latest News

Pharmacy Assurance Phase 3 opens Monday 30 September 2019

03 September 2019   (0 Comments)
Posted by: Caroline Oxley
Share |

We are pleased to inform you that we will be progressing to Phase 3 of Pharmacy Assurance in England and Wales on Monday 30th September 2019, as we now have sufficient resources in place to rollout to widen the criteria for the types of study that can be accepted through Pharmacy Assurance.

 

We are currently accepting Phase I, II and II/III oncology studies taking place in secondary care in the NHS; Phase 3 of Pharmacy Assurance will extend this to include all Phase III non-oncology studies.

 

Both the IRAS and HRA websites will be updated shortly with this information and a further email will be sent out on 30th September 2019 with full details.

 

In the meantime, we will continue to accept Phase I, II and II/III oncology studies and look forward to receiving Phase III non-oncology studies for review from 30th September 2019.

 

If you have any questions about the Pharmacy Assurance service, please contact the Pharmacy Assurance team at hra.pharmacyassurance@nhs.net.


 

© 2013 BNMS unless otherwise stated.
The BNMS is a registered as a company in England and Wales with number 08082786.  The BNMS is a charity governed by the rules of the Charity Commission for England and Wales - Registered Number 1150234.  Registered Office: The Royal College of Physicians, 11 St. Andrew's Place, Regent's Park, London NW1 4LE.
The British Nuclear Medicine Society is not able to give specific clinical advice to members of the public. If you are concerned about your scan or therapy please seek the opinion of a nuclear medicine clinician where you were seen or the clinician who referred you to the department or your GP.
Enquiries related to issues such as internships and work experience opportunities, should be directed to the relevant professional body e.g., for radiologists, this will be the Royal College of Radiologists.